These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Pharmacoeconomic aspects in the treatment of chronic obstructive bronchitis].
    Author: Leshchenko IV, Livshits VR, Romanovskikh AG, Spiridonova KM, Patrik AA.
    Journal: Ter Arkh; 2002; 74(3):38-40. PubMed ID: 11980119.
    Abstract:
    AIM: Analysis of pharmacological cost-efficiency at various stages of medical care for patients with chronic obstructive bronchitis (COB). MATERIAL AND METHODS: The cost of COB patients treatment, including that of hospital stay, ambulance call, outpatient treatment, cost of medicines. RESULTS: In direct medical expenditures, the cost of hospital stay is the highest. Most of this money (80%) is spent on management of severe exacerbation of COB in critical care units. CONCLUSION: It would be valid to set up specialized outpatient service for follow-up and treatment of COB patients.
    [Abstract] [Full Text] [Related] [New Search]